Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-29

FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a generic fixed-dose combination tablet of lamivudine and zidovudine under an Original Application (ANDA) by Macleods Pharmaceuticals Limited f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine and Zidovudine (Lamivudine and Zidovudine)

Snippet

ORIG AP for LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE)